MED Stock Analysis: Buy, Sell, or Hold?
MED - Medifast, Inc.
$10.62
-0.40 (-3.63%)
βΌ
5d:
-11.06%
30d:
-15.91%
90d:
+5.15%
WAIT
LOW Confidence
Analysis Updated: Jun 23, 2026 12:00 AM ET
Earnings: Aug 03, 2026
Get Alerted When MED Hits Your Target Price
Join 10,000+ traders who never miss a move
You're in! Check your email to confirm and set your target price.
100% Free
No spam, ever
Unsubscribe anytime
Interactive Price Chart (1 Month)
Loading chart...
Loading historical data...
Bottom Line:
βΈοΈ WAIT FOR STABILIZATION: MED is down 11.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
βΈοΈ WAIT FOR STABILIZATION: MED is down 11.1% over the last 5 days. While fundamentals may be solid, catching a falling knife is risky. Wait for price to stabilize before entering.
In-depth Analysis How we analyze
Valuation Analysis: MED is currently trading at $10.62, which is considered oversold relative to its 30-day fair value range of $11.49 to $12.77.
Technical Outlook: Technically, MED is in a uptrend. The price is currently testing key support at $11.91. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+13.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Technical Outlook: Technically, MED is in a uptrend. The price is currently testing key support at $11.91. A bounce from this level would confirm strength, while a break below could signal further downside. Short-term momentum is weak, with the stock down 3.6% recently.
Market Sentiment: The stock shows a mixed technical setup (40/100), with neutral trendline and momentum signals. Wall Street analysts see significant upside, with an average price target of $12.00 (+13.0%). Current signals suggest waiting for a better entry point before initiating new positions.
Quick Decision Summary
Current Position
OVERSOLD
Historical Trading Range
$11.49 -
$12.77
Company Quality Score
55/100
(HOLD)
Volume Confirmation
HIGH
Confidence Score
74.7%
All Signals
- BULLISH: Price oversold vs 30-day range
- NEUTRAL: Mixed technical signals (40/100)
- BULLISH: High volume confirmation
- BEARISH: Downward momentum (-3.6%)
- BULLISH: Trading below Wall St target ($12.00)
- WARNING: Recommendation downgraded due to -11.1% 5-day decline - wait for stabilization
Trading Range Analysis
30-Day Trading Range
$11.49 -
$12.77
Current vs Trading Range
OVERSOLD
Support & Resistance Levels
Support Level
$11.91
Resistance Level
$13.18
Current Trend
Uptrend
Technical data as of
Jun 9, 2026
Fundamental Context
Forward P/E (Next Year Est.)
-17.70
Wall Street Target
$12.00
(+13.0%)
Revenue Growth (YoY)
-34.3%
Earnings Growth (YoY)
-87.2%
Profit Margin
-5.8%
Share & Embed Analysis
Last updated: June 24, 2026 7:13 AM ET
Data refreshes hourly during market hours. Next update: 8:13 AM
Data refreshes hourly during market hours. Next update: 8:13 AM
π₯ Top Stocks Breaking Out Now
| Ticker | Score | Recommendation | Change % |
|---|
Technical Signals Check
Is MED showing a specific setup today?
Insider Activity (6 Months)
1
Buys
0
Sells
+
Net
INSIDERS BUYING
Recent Transactions
Daniel R Chard
BUY
17678 shares
2026-03-20
Top Rated Personal Services Stocks
Top-rated stocks in Personal Services by analyst ratings.